search
Back to results

Biofreeze and the Effect on Knee Osteoarthritis

Primary Purpose

Knee Osteoarthritis

Status
Unknown status
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Biofreeze 4 % Topical Gel
Biofreeze placebo gel
Sponsored by
Memorial University of Newfoundland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Osteoarthritis, Pain management, Menthol, Knee

Eligibility Criteria

50 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Men and women aged 50-80 years
  2. Body mass index (BMI) less than 40
  3. Knee osteoarthritis of grade one or more according to Kellgren-Lawrence scale
  4. Average pain intensity of grade 4 or more on a 10-point visual analogue scale for at least 6 months.
  5. Meet clinical and radiographic criteria of the American College of Rheumatology (ACR) for knee OA

Exclusion Criteria:

  1. Acute arthritis,
  2. Rheumatologic diseases
  3. Infective arthritis
  4. Traumatic arthritis,
  5. History of knee replacement surgery
  6. Patients receiving multiple corticosteroid injections (Greater than 2 injections)

Sites / Locations

  • Memorial University, Faculty of Medicine Department of SurgeryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Topical analgesia (+Menthol)

Topical analgesia (-Menthol)

Arm Description

Biofreeze Topical Gel with active ingredient (Menthol 4%)

Biofreeze Topical Gel with no active ingredient (Menthol 0%)

Outcomes

Primary Outcome Measures

Efficacy comparison of (Biofreeze) Menthol 4%, Menthol 0% as measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), version 3.0
Endpoint is a non-inferiority statistical comparison. Comparison is based off of analysis of identical questionnaires administered at baseline and at 4 weeks

Secondary Outcome Measures

Full Information

First Posted
April 15, 2020
Last Updated
February 22, 2021
Sponsor
Memorial University of Newfoundland
search

1. Study Identification

Unique Protocol Identification Number
NCT04351594
Brief Title
Biofreeze and the Effect on Knee Osteoarthritis
Official Title
Effect of a Menthol Gel (Biofreeze) on the Symptoms Associated With Knee Osteoarthritis: a Double-blind Randomized Control Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2020 (Actual)
Primary Completion Date
November 1, 2021 (Anticipated)
Study Completion Date
November 1, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Memorial University of Newfoundland

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Knee osteoarthritis (OA) is a progressive disease that can be accompanied by considerable joint pain and dysfunction. It is a goal in the medical field to find effective treatments for knee OA that are non-interventional, have minor or no negative side effects, and are relatively easy to administer for the patient and health care professionals. Biofreeze, a topical analgesic containing menthol, is an easily accessible gel, with no known serious negative side effects. If the application of Biofreeze can reduce the pain and dysfunction associated with knee OA, it could be an effective treatment for patients. The objective of the study is to assess how 4 weeks of Biofreeze application to a knee affected by OA effects pain and dysfunction associated with the disease.
Detailed Description
Knee osteoarthritis (OA) is a disease which results in deterioration with articular cartilage and bone tissue of the knee joint (Felson et al., 2000). The disease is prevalent in the elderly and as it progresses, can cause serious joint pain and a lot of knee dysfunction (National Collaborating Centre for Chronic Conditions, 2008). In addition to surgical intervention, there are currently a multitude of non-surgical interventional treatments which have been used to help patients deal with the pain and dysfunction associated with OA. This includes exercise, weight loss, orthotics, topical and oral medications, therapeutic modalities and even more (Dadabo, Fram, and Jayabalan, 2019). While the aforementioned treatments all have advantages, there are some disadvantages including but not limited to; negative side effects of oral medications, exercise intolerance secondary to pain as well as risk of injury, difficulty in maintaining a healthy diet, cost associated with receiving therapeutic modalities, all of which could make the treatments impractical for some or all patients. It is a goal for health researchers, to discover a treatment which can significantly reduce pain and dysfunction associated with knee OA while also limiting the negative side effects or difficulties associated with using the treatment. There are a few studies which have looked at the effect of topical treatments on symptoms associated with knee OA. One study performed a double-blind, randomized, placebo-controlled clinical trial using linseed oil (Mosavat et al., 2018). This study found that the administration of linseed oil significantly reduced pain and other symptoms associated with knee OA compared to the control. Another study used a topical non-steroidal anti-inflammatory drug (NSAID) to treat knee OA pain (Bookman, Williams, and Shainhouse, 2004).This study also found that the treatment helped with pain, the drug was accompanied with some local skin irritation and minimal systemic side effects (Bookman et al.,2004). Biofreeze, a topical analgesic containing menthol, is a relatively cost-efficient item with no known adverse side effects. If the administration of Biofreeze to a knee affected with OA relieves pain and symptoms associated with OA, it could be a safe and effective treatment for knee OA patients to use. The primary objective in this study is to assess the affects of a menthol based topical agent on osteoarthritis of the knee. Outcome measures are based on scores obtained from the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The WOMAC questionnaire is a patient-administered questionnaire that contains 24 questions, targeting areas of pain, stiffness and physical function, and can be completed in less than 5 minutes. The questionnaire will be given to the patients at the beginning and at the end of the 4 week study to compare differences.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
Keywords
Osteoarthritis, Pain management, Menthol, Knee

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Topical analgesia (+Menthol)
Arm Type
Experimental
Arm Description
Biofreeze Topical Gel with active ingredient (Menthol 4%)
Arm Title
Topical analgesia (-Menthol)
Arm Type
Placebo Comparator
Arm Description
Biofreeze Topical Gel with no active ingredient (Menthol 0%)
Intervention Type
Drug
Intervention Name(s)
Biofreeze 4 % Topical Gel
Other Intervention Name(s)
Menthol 4% Topical gel
Intervention Description
Biofreeze gel with active manufactured ingredient (Menthol 4%)
Intervention Type
Other
Intervention Name(s)
Biofreeze placebo gel
Other Intervention Name(s)
Placebo gel (Menthol 0%)
Intervention Description
Biofreeze gel with no active manufactured to have the same look, feel and odour as Biofreeze topical gel.
Primary Outcome Measure Information:
Title
Efficacy comparison of (Biofreeze) Menthol 4%, Menthol 0% as measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), version 3.0
Description
Endpoint is a non-inferiority statistical comparison. Comparison is based off of analysis of identical questionnaires administered at baseline and at 4 weeks
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women aged 50-80 years Body mass index (BMI) less than 40 Knee osteoarthritis of grade one or more according to Kellgren-Lawrence scale Average pain intensity of grade 4 or more on a 10-point visual analogue scale for at least 6 months. Meet clinical and radiographic criteria of the American College of Rheumatology (ACR) for knee OA Exclusion Criteria: Acute arthritis, Rheumatologic diseases Infective arthritis Traumatic arthritis, History of knee replacement surgery Patients receiving multiple corticosteroid injections (Greater than 2 injections)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nick Smith, MD (FRCSC)
Phone
709-746-6512
Email
nicksmith@munmed.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Justin Murphy, MD, MSc
Phone
709-765-2161
Email
jrmurphy@mun.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nick Smith, MD (FRCSC)
Organizational Affiliation
Memorial University Orthopaedic Surgery
Official's Role
Principal Investigator
Facility Information:
Facility Name
Memorial University, Faculty of Medicine Department of Surgery
City
St. John's
State/Province
Newfoundland and Labrador
ZIP/Postal Code
A1B3V6
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nick Smith, MD (FRCSC)
Phone
(709)746-6512
Email
nicksmith@munmed.ca
First Name & Middle Initial & Last Name & Degree
Justin Murphy, MD, MSc
Phone
(709)765-2161
Email
jrmurphy@mun.ca

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Investigators plan to share the study results as a whole but no plans to share individual results.
Citations:
PubMed Identifier
12975186
Citation
Airaksinen OV, Kyrklund N, Latvala K, Kouri JP, Gronblad M, Kolari P. Efficacy of cold gel for soft tissue injuries: a prospective randomized double-blinded trial. Am J Sports Med. 2003 Sep-Oct;31(5):680-4. doi: 10.1177/03635465030310050801.
Results Reference
background
PubMed Identifier
15313991
Citation
Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004 Aug 17;171(4):333-8. doi: 10.1503/cmaj.1031793.
Results Reference
background
PubMed Identifier
29705472
Citation
Mosavat SH, Masoudi N, Hajimehdipoor H, Emami Meybodi MK, Niktabe Z, Tabarrai M, Ghorat F, Khodadoost M. Efficacy of topical Linum usitatissimum L. (flaxseed) oil in knee osteoarthritis: A double-blind, randomized, placebo-controlled clinical trial. Complement Ther Clin Pract. 2018 May;31:302-307. doi: 10.1016/j.ctcp.2018.03.003. Epub 2018 Mar 14. No abstract available.
Results Reference
background
PubMed Identifier
22976810
Citation
Topp R, Brosky JA Jr, Pieschel D. The effect of either topical menthol or a placebo on functioning and knee pain among patients with knee OA. J Geriatr Phys Ther. 2013 Apr-Jun;36(2):92-9. doi: 10.1519/JPT.0b013e318268dde1.
Results Reference
background

Learn more about this trial

Biofreeze and the Effect on Knee Osteoarthritis

We'll reach out to this number within 24 hrs